Biostar Pharmaceuticals, Inc. (BSPM)
-NasdaqGM 0.79 
0.01(1.28%) 3:59PM EDT
| Prev Close: | 0.78 |
|---|
| Open: | 0.78 |
|---|
| Bid: | 0.61 x 800 |
|---|
| Ask: | 0.97 x 5300 |
|---|
| 1y Target Est: | 7.00 |
|---|
| Beta: | 1.91 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.77 - 0.79 |
|---|
| 52wk Range: | 0.62 - 2.00 |
|---|
| Volume: | 16,444 |
|---|
| Avg Vol (3m): | 22,205 |
|---|
| Market Cap: | 9.16M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -2.22 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BIOSTAR PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials(Tue, May 21)
- Biostar Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 16)
- Biostar Pharmaceuticals, Inc. Announces First Quarter 2013 Financial ResultsPR Newswire(Thu, May 16)
- BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- Q1 2013 Biostar Pharmaceuticals Inc Earnings Release - After Market CloseCCBN(Wed, May 15)
- Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2013 First Quarter Earnings Conference Call on Thursday, May 16, 2013 at 9:00 a.m. ETPR Newswire(Tue, May 14)
- BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing RuleEDGAR Online(Mon, May 6)
- BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Tue, Apr 16)
- Biostar Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha(Mon, Apr 15)
- Biostar Pharmaceuticals, Inc. Reports 2012 ResultsPR Newswire(Mon, Apr 15)
- Q4 2012 Biostar Pharmaceuticals Inc Earnings Release - Before Market OpenCCBN(Mon, Apr 15)
- BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Apr 15)
- Biostar Pharmaceuticals, Inc. to Host Fiscal 2012 Year End Earnings Conference Call on Monday, April 15, 2013 at 9:30 a.m. ETPR Newswire(Tue, Apr 9)
- BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and ExEDGAR Online(Fri, Mar 15)
- Current Ratio: Not Always The Most Efficient And Reliable Screening Criterionat Seeking Alpha(Sun, Feb 24)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.20 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-11)
: | N/A |
|---|
| Quarterly EPS Est
(Mar-11)
: | N/A |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Biostar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the Peoples Republic of China.
View More